Mayinglong Bezornil Hemorrhoidal
NDC Package 30803-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mayinglong Bezornil Hemorrhoidal is usestemporarily helps relieve:anorectal burning, itching, and discomfort associated with hemorrhoidstemporarily:reduces the swelling associated with irritated hemorrhoidal tissue and other anorectal disordersshrinks hemorrhoidal tissueprotects inflamed perianal skin and irritated areas. Marketed by Mayinglong Pharmaceutical Group Co Ltd, this product is identified by NDC 30803-001 and is authorized under FDA application part346.

Identification & Billing

NDC Package Code
30803-001-01
Package Description
10 g in 1 TUBE, WITH APPLICATOR
Product Code
30803-001
11-Digit Billing Format
30803000101

Clinical Specifications

Proprietary Name
Mayinglong Bezornil Hemorrhoidal
Dosage Form
-
Usage Information
Usestemporarily helps relieve:anorectal burning, itching, and discomfort associated with hemorrhoidstemporarily:reduces the swelling associated with irritated hemorrhoidal tissue and other anorectal disordersshrinks hemorrhoidal tissueprotects inflamed perianal skin and irritated areas

Regulatory & Marketing

Labeler Name
Mayinglong Pharmaceutical Group Co Ltd
FDA Application #
part346
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-28-2013
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 30803-001-01 identifies a specific commercial package of 10 g in 1 tube, with applicator of Mayinglong Bezornil Hemorrhoidal, labeled by Mayinglong Pharmaceutical Group Co Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mayinglong Pharmaceutical Group Co Ltd on August 28, 2013. The current certification is valid through December 31, 2018.

How is this Mayinglong Pharmaceutical Group Co Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 30803000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
30803-001-01
11-Digit CMS (5-4-2)
30803-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.